investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Hugh S. Gannon
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hugh S. Gannon
Dana-Farber Cancer Institute
Boston, United States
Related projects
William B Kinlaw
Fatty Acids and Cancer
Breast
Stephen J Elledge
Analysis of the Mammalian DNA Damage Response
Breast
Joseph Yesselman
Toward Atomic-Accuracy Design of Functional RNAs
Breast
Joshua Labaer
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Breast
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
Harold M Swartz
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
Breast
Radiation Oncology
W Todd Miller
Substrate Specificity of Non-receptor Tyrosine Kinases
Breast
Alvaro Monteiro
Charting the BRCT Domain Network
Breast
Fabio Petrocca
Noxa-mediated mechanisms of proteasome addiction in basal-like breast cancer
Breast
